Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Viktor RománNika AdhamAndrew G FoleyLynsey HanrattyBence FarkasBalázs LendvaiBéla KissPublished in: Psychopharmacology (2021)
In the present study, cariprazine effectively reversed core behavioral deficits and hyperactivity present in juvenile and young adult autistic-like rats. These findings indicate that cariprazine may be useful in the treatment of ASD symptoms.